Dr. Geiger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105
Education & Training
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1994 - 1997
Yale School of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 1999 - 2025
CT State Medical License 1997 - 2000- American Board of Pathology Clinical Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 245 citationsTargeting REGNASE-1 programs long-lived effector T cells for cancer therapyJun Wei, Lingyun Long, Wenting Zheng, Yogesh Dhungana, Seon Ah Lim
Nature. 2019-12-01 - 62 citationsIntegrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes.Terrence L. Geiger, Phuong L. Nguyen, David Leitenberg, Richard A. Flavell
Blood. 2001-10-15 - 593 citationsChimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemiaChihaya Imai, Keichiro Mihara, M. Andreansky, I. C. Nicholson, C H Pui
Leukemia. 2004-04-01
Journal Articles
- IL-6 Promotes T Cell Proliferation and Expansion Under Inflammatory Conditions in Association with Low-Level RORγt ExpressionTerrence Geiger, MD, The Journal of Immunology
Grant Support
- Treatment Of Autoimmunity With Regulatory T LymphocytesNational Institute Of Allergy And Infectious Diseases2009–2012
- Treatment Of Autoimmunity With Receptor-Modified T CellsNational Institute Of Allergy And Infectious Diseases2004–2008
- Inducing Immune Tolerance With Receptor Modified T CellsNational Institute Of Allergy And Infectious Diseases2001–2003
- Treatment Of EAE Using Genetically Modified CTLNational Institute Of Allergy And Infectious Diseases1999–2001
- Treatment Of EAE Using Genetically Modified CTLNational Institute Of Allergy And Infectious Diseases1997–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
